Perfil
En la actualidad, Pat Cotroneo es Director Financiero y Vicepresidente Senior de Finanzas de FibroGen, Inc. El Sr. Cotroneo ocupó anteriormente el cargo de interventor de Systemix, Inc. y de interventor de Genetic Therapy, Inc. Se licenció en la Universidad de San Francisco.
Antiguos cargos conocidos de Pat Cotroneo.
| Empresas | Cargo | Fin |
|---|---|---|
| KYNTRA BIO, INC. | Director Financiero/CFO | 07/09/2021 |
Systemix, Inc.
Systemix, Inc. Medical/Nursing ServicesHealth Services Develops cell-based gene therapies for diseases | Comptroller/Controller/Auditor | 01/01/2000 |
Genetic Therapy, Inc.
Genetic Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Develops human gene therapy delivery products | Comptroller/Controller/Auditor | 01/01/2000 |
Formación de Pat Cotroneo.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Systemix, Inc.
Systemix, Inc. Medical/Nursing ServicesHealth Services Develops cell-based gene therapies for diseases | Health Services |
Genetic Therapy, Inc.
Genetic Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Develops human gene therapy delivery products | Commercial Services |
FibroGen, Inc.
FibroGen, Inc. Pharmaceuticals: MajorHealth Technology Develops biotechnology-based drugs | Health Technology |
University of San Francisco
University of San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Bolsa de valores
- Insiders
- Pat Cotroneo
















